Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Finasteride worsens seizures in epilepsy rats and speeds up epileptogenesis in mice.

Treatment during development affects hormone balance and sexual behavior in male rats.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Both genetic and lifestyle factors significantly affect female hair loss.

Leydig cells can cause testosterone-secreting adrenal tumors in women.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.